$10.25
+0.09 (+0.89%)
As of Jun 21, 10:04 PM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 6 60%
Hold 4 40%
Sell 0 0%
Price Target
Analyst Price Target +677.1% upside
Low Target $56.38
Average Target $79.65
High Target $102.54
Current Price $10.25
Current
$10.25
Target
$79.65
$56.38 $79.65 avg $102.54
Scenario Analysis
Bear Case
$56.38
450.0%
Low target
Base Case
$79.65
+677.1%
Avg target
Bull Case
$102.54
+900.4%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$28.44
-64.0% from high
52-Week Low
$9.23
+11.1% from low
50-Day SMA
$14.19
-27.8% vs SMA
200-Day SMA
$20.75
-50.6% vs SMA
RSI (14)
65.7
Neutral
Target vs 52W High
$79.65
+180.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.7%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +29.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +37.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +35.2%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +219.0%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +176.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -32.3%